CompaniesSanthera Pharmaceuticals
Santhera Pharmaceuticals logo

Santhera Pharmaceuticals

active
Pratteln, Switzerland
Founded 2004
Website
About

Orphan Neuromuscular Disease Targets

Areas of Focus

Categories

Small Molecule Pharmaceutical
Team (13)
Andreas Missy
Andreas Missy
Santhera Pharmaceuticals
team_member
Bradley C. Meyer
Bradley C. Meyer
Santhera Pharmaceuticals
team_member
Catherine Isted
Catherine Isted
Santhera Pharmaceuticals
team_member
Dario Eklund
Dario Eklund
Santhera Pharmaceuticals
team_member
Dr. Melanie Rolli
Dr. Melanie Rolli
Santhera Pharmaceuticals
team_member
Geert Jan van Daal, MD, PhD
Geert Jan van Daal, MD, PhD
Santhera Pharmaceuticals
team_member
View all 13 team members →
Clinical Trials (32)
View all

Total Trials

32

As Lead Sponsor

27

As Collaborator

5

Total Enrollment

2,823

By Phase

PHASE4: 2PHASE1: 4PHASE2: 8PHASE1/PHASE2: 1PHASE3: 9

By Status

COMPLETED: 24TERMINATED: 2NO_LONGER_AVAILABLE: 2RECRUITING: 1UNKNOWN: 1WITHDRAWN: 1AVAILABLE: 1
Clinical Trials Pipeline28 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT00993967
NCT01027884
NCT02774005
NCT02771379
NCT02814019
Hover over trial bars to see details

Recent Trials

NCT06713135Lead Sponsor
A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy
PHASE4Recruiting
80 participants
Started: Nov 10, 2024 · Completed: Sep 30, 2028
NCT06689527Lead Sponsor
Evaluation of Vamorolone CYP3A4 Induction on Midazolam (a Sensitive CYP 3A4 Substrate) Pharmacokinetics
PHASE1Completed
18 participants
Started: Aug 13, 2024 · Completed: Oct 16, 2024
NCT06649409Lead Sponsor
Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects
PHASE1Completed
30 participants
Started: Jun 5, 2024 · Completed: Jul 6, 2024
NCT05166109Collaborator
A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)
PHASE2Completed
46 participants
Started: Jul 7, 2022 · Completed: Aug 18, 2025
NCT05185622Lead Sponsor
A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
PHASE2Completed
54 participants
Started: Mar 21, 2022 · Completed: Jul 16, 2024
View all 32 trials →
Locations (1)
Headquarters
Pratteln, Switzerland
Map

Loading map...